Conditions: Stable Coronary Artery Disease
Keywords: Stable Coronary Artery Disease, CAD
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 50
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the pharmacodynamic effect of ticagrelor in African American patients with stable coronary artery disease.

Detailed description:
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor versus Clopidogrel in African American Patients with Stable Coronary Artery Disease

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Ticagrelor intervention 2: Clopidogrel
Intervention descriptions: intervention 1: Min - 90mg/Max - 180mg tablets (loading dose) intervention 2: 75mg (once daily)/Max - 600mg tablets (loading dose)

Protocol document: